Patient from JAMA Psoriasis. 2011, issue of JAMA includes an article about medications used to treat psoriasis. Access to Health Care in Patients With Psoriasis and Psoriatic Arthritis: Data From National Psoriasis Foundation Survey Panels. Primary reasons for not seeking treatments included giving up on disease treatment (27.
Patient perspectives in the management of psoriasis: Results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey. K.B. et al, Guidelines of care for the management of psoriasis and psoriatic arthritis: section 1. JAMA Dermatol. 2013;149:1180 1185. In response to the rising cost of treating psoriasis and psoriatic arthritis, the National Psoriasis Foundation (NPF) has teamed with 32 other patient advocacy and medical organizations to help ensure treatments for lifelong, chronic diseases remain accessible. Biologic drugs are among the most effective treatments for nail psoriasis, particularly when topical treatments have failed, according to two recent reviews of clinical trials and other studies on therapy options for the disease.
Patient Satisfaction and Quality of Life in Psoriasis and Psoriatic Arthritis JAMA. 2014;312:2676-2677. doi:10.1001/jama.2014.12494. IMPORTANCE: Psoriasis and psoriatic arthritis inflict significant morbidity. Data on undertreatment, treatment use, and treatment satisfaction are paramount to identify priority areas for advocacy, education, and research to improve patient outcomes. JAMA: The Journal of the American Medical Association, 312(24), 2676-2677. The location of the disease and the presence of psoriatic arthritis also affect the choice of therapy. Psoriasis of the hand, foot, or face can be debilitating functionally or socially and may deserve a more aggressive treatment approach. Ustekinumab associated with flares of psoriatic arthritis. JAMA Dermatol 2013; 149:1410.
References In Patient Perspectives In The Management Of Psoriasis: Results From The Population-based Multinational Assessment Of Psoriasis And Psoriatic Arthritis Survey
Treatments for moderate-to-severe psoriasis often do not meet patient and physician expectations due to adverse effects, lack of long-term efficacy, and inconvenient administration schedules. Patients had psoriatic arthritis with skin lesions at least 2cm in diameter. JAMA Dermatol 2013 Oct;149(10):1180-5. doi: 10.1001/jamadermatol.2013.5264. The National Psoriasis Foundation conducts biannual surveys to identify undertreatment, treatment trends, and treatment satisfaction among patients with psoriasis and psoriatic arthritis. JAMA Dermatol. doi:10.1001/jamadermatol.2013.5264. Psoriatic arthritis is often associated with psoriasis of the skin or nails. PsA is characterized by stiffness, pain, swelling, and tenderness of the joints and surrounding ligaments and tendons. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. JAMA Dermatol. doi:10.1001/jamadermatol.2013.5264. Etanercept offers patients with psoriatic arthritis and psoriasis a new therapeutic option for control of their disease. Auerbach, R, Eisen, AZ, and Bunim, JJ. Methotrexate therapy in psoriatic arthritis. JAMA. Setting: Patients with psoriasis and psoriatic arthritis in the general community in the United States. JAMA Dermatology, 149(6), 717-721. Many patients with psoriasis and psoriatic arthritis are not benefiting from the expanding array of treatments now available to combat these serious autoimmune disorders, researchers led by a UC Davis dermatologist report in a new study published online today by JAMA Dermatology. Many patients with psoriasis and psoriatic arthritis are not benefiting from the expanding array of treatments now available to combat these serious autoimmune disorders, researchers led by a UC Davis dermatologist report in a new study published online today by JAMA Dermatology.